Skip to content

Clinical application of high-flow nasal cannula therapy in patients with post-traumatic ARDS

Clinical application of high-flow nasal cannula therapy in patients with post-traumatic ARDS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017313
Enrollment
Unknown
Registered
2018-07-24
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-traumatic ARDS

Interventions

HFNC group:High-flow nasal cannula oxygen
NIV group:non-invasive ventilation

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients group one: 1. Within 24h after trauma; 2. 200mmHg < PO2/FiO2 = 300mmHg. Patients group two: 1. Within 24h after trauma; 2. 100mmHg < PO2/FiO2 = 200mmHg. Patients group three: 1. The patients are diagnosed as trauma patients. 2. The patients with endotracheal intubation must pass spontaneous breathing test (SBT), can be successfully extubated.

Exclusion criteria

Exclusion criteria: Patients group one: 1. Less than 18 years old; 2. The informed consent can not be obtained; 3. Other organ failure except lung; 4. Tracheotomy. Patients group two: 1. Less than 18 years old; 2. The informed consent can not be obtained; 3. Severe ARDS requiring immediate endotracheal intubation: respiratory frequency >40 times/min, severe hypoxia, PO2/FiO2 < 200mmHg,severe respiratory acidosis, Arterial blood PH <7.25, GCS<8; 4. There are NIV taboos: oral and facial trauma, poor expectoration ability, active gastrointestinal bleeding. 5. Other organ failure except lung; 6. Tracheotomy. Patients group three: 1. Less than 18 years old; 2. The informed consent can not be obtained; 3. There are NIV taboos: oral and facial trauma, poor expectoration ability, active gastrointestinal bleeding. 4. Tracheotomy.

Design outcomes

Primary

MeasureTime frame
arterial blood gas;respiratory rate;blood pressure;change and time of respiratory support;whether invasive ventilation (endotracheal intubation) and time;

Secondary

MeasureTime frame
dyspnea score;comfort score;facial skin breakage;respiratory and extrapulmonary complications;length of stay in ICU;length of stay in hospital;discharge (death, healed / improved);

Countries

China

Contacts

Public ContactLi Yujie

Northern Jiangsu People's Hospital

34504287@qq.com+86 18051063880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026